1. Section 6002 of the Patient Protection and Affordable Care Act. Public Law 111–148. http://www.gpo.gov/fdsys/pkg/PLAW-111publ148/pdf/PLAW-111publ148.pdf . Accessed 26 Jan 2017.
2. Centers for Medicare and Medicaid Services. 42 CFR Parts 402 and 403. Medicare, Medicaid, Children’s Health Insurance Programs; transparency reports and reporting of physician ownership or investment interests. Federal Register 78. 2013. https://www.cms.gov/OpenPayments/Downloads/Affordable-Care-Act-Section-6002-Final-Rule.pdf . Accessed 26 Jan 2017.
3. Official website for Open Payments. https://www.cms.gov/OpenPayments/index.html . Accessed 26 Jan 2017.
4. US Senate Special Committee on Aging. Grassley, Kohl say public should know when pharmaceutical makers give money to doctors. Press release. September 7, 2007. http://www.aging.senate.gov/press-releases/grassley-kohl-say-public-should-know-when-pharmaceutical-makers-give-money-to-doctors . Accessed 26 Jan 2017.
5. Chimonas S, Rozario NM, Rothman DJ. Show us the money: lessons in transparency from state pharmaceutical marketing disclosure laws. Health Serv Res. 2010;45:98–114.